| EQA 2027 - Tumour markers and general hormone testing (CIMD) |
|---|
|
Expert Biologists - Program Coordinators:
Marie LOPEZ and Laetitia SELMAN EQA performed since 1977
Number of analytical sites registered in 2026: 697 |
1 – Program overview
This external quality assessment program evaluates the accuracy of tumour marker and general hormone assays, with an interlaboratory comparison by peer group.
Statistical reports are sent with supporting comments from the expert clinical biologists / program coordinators.
Participating labs can choose to be assessed for all the analytes of this program, or simply a subset of analytes of interest.
| Sample volume: if necessary, order an additional kit. |
2 – Assessment frequency
Number of surveys per year: 6
Number of control samples per survey: 1 or 2
Number of samples per year: 9
3 – List of analytes assessed
|
|
|
4 – Description of the control samples
Lyophilised human control serum (samples to be resuspended in 3 mL of distilled water).
| | Legal notices and privacy policy | General terms of sale | | Last updated: 13 October 2026 | Copyright © 2011-2026 ProBioQual All rights reserved |